Literature DB >> 28067897

Pathological changes in basement membranes and dermal connective tissue of skin from patients with hereditary cystatin C amyloid angiopathy.

Asbjorg Osk Snorradottir1,2, Helgi J Isaksson2, Saevar Ingthorsson3,4, Elias Olafsson5,6, Astridur Palsdottir1, Birkir Thor Bragason1.   

Abstract

Hereditary cystatin C amyloid angiopathy (HCCAA) is a genetic disease caused by a mutation in the cystatin C gene. Cystatin C is abundant in cerebrospinal fluid and the most prominent pathology in HCCAA is cerebral amyloid angiopathy due to mutant cystatin C amyloid deposition with associated cerebral hemorrhages, typically in young adult carriers. Analyses of post-mortem brain samples shows that pathological changes are limited to arteries and regions adjacent to arteries. The severity of pathological changes at post-mortem has precluded the elucidation of the evolution of histological changes. Mutant cystatin C deposition in carriers is systemic and has, for example, been described in the skin, suggesting similar pathological mechanisms both in the brain and outside of the central nervous system. The aim of this study was to use skin biopsies from asymptomatic and symptomatic carriers to study intermediate events in HCCAA pathogenesis. We found that cystatin C deposition in minimally affected samples was limited to the basement membrane (BM) between the dermis and epidermis. When the deposits were more advanced, they extended to other BM regions in the skin. Our results showed that the immunoreactivity of the BM protein COLIV was increased to a similar extent in all carrier biopsies and cystatin C deposits were in close association with COLIV. The density of fibroblasts in the upper dermis of carrier skin was increased, whereas the distribution of other cell types examined did not differ compared with control biopsies. COLIV and cystatin C immunoreactivity in carrier biopsies was closely associated with the fibroblasts. The results of this study, in conjunction with our previous results regarding pathological BM changes in leptomeningeal arteries of patients, suggest that BM changes are early and important events in HCCAA pathogenesis that could facilitate cystatin C deposition and aggregation.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28067897     DOI: 10.1038/labinvest.2016.133

Source DB:  PubMed          Journal:  Lab Invest        ISSN: 0023-6837            Impact factor:   5.662


  46 in total

1.  On the role of monocytes/macrophages in the pathogenesis of central nervous system lesions in hereditary cystatin C amyloid angiopathy.

Authors:  L Thorsteinsson; G Georgsson; B Asgeirsson; M Bjarnadóttir; I Olafsson; O Jensson; G Gudmundsson
Journal:  J Neurol Sci       Date:  1992-04       Impact factor: 3.181

Review 2.  Epithelial-mesenchymal transition in the skin.

Authors:  Motonobu Nakamura; Yoshiki Tokura
Journal:  J Dermatol Sci       Date:  2010-12-05       Impact factor: 4.563

3.  Vascular basement membrane pathology and Alzheimer's disease.

Authors:  C Zarow; E Barron; H C Chui; L S Perlmutter
Journal:  Ann N Y Acad Sci       Date:  1997-09-26       Impact factor: 5.691

4.  Instability of the amyloidogenic cystatin C variant of hereditary cerebral hemorrhage with amyloidosis, Icelandic type.

Authors:  L Wei; Y Berman; E M Castaño; M Cadene; R C Beavis; L Devi; E Levy
Journal:  J Biol Chem       Date:  1998-05-08       Impact factor: 5.157

5.  Intracellular accumulation of the amyloidogenic L68Q variant of human cystatin C in NIH/3T3 cells.

Authors:  M Bjarnadottir; B S Wulff; M Sameni; B F Sloane; D Keppler; A Grubb; M Abrahamson
Journal:  Mol Pathol       Date:  1998-12

6.  Heparan sulfate proteoglycan expression in cerebrovascular amyloid beta deposits in Alzheimer's disease and hereditary cerebral hemorrhage with amyloidosis (Dutch) brains.

Authors:  J van Horssen; I Otte-Höller; G David; M L Maat-Schieman; L P van den Heuvel; P Wesseling; R M de Waal; M M Verbeek
Journal:  Acta Neuropathol       Date:  2001-12       Impact factor: 17.088

7.  Amyloid fibrils in hereditary cerebral hemorrhage with amyloidosis of Icelandic type is a variant of gamma-trace basic protein (cystatin C).

Authors:  J Ghiso; O Jensson; B Frangione
Journal:  Proc Natl Acad Sci U S A       Date:  1986-05       Impact factor: 11.205

8.  Immunohistochemical characterization of the amyloid deposits and quantitation of pertinent cerebrospinal fluid proteins in hereditary cerebral hemorrhage with amyloidosis.

Authors:  H Löfberg; A O Grubb; E K Nilsson; O Jensson; G Gudmundsson; H Blöndal; A Arnason; L Thorsteinsson
Journal:  Stroke       Date:  1987 Mar-Apr       Impact factor: 7.914

9.  Reduction of fibroblast size/mechanical force down-regulates TGF-β type II receptor: implications for human skin aging.

Authors:  Gary J Fisher; Yuan Shao; Tianyuan He; Zhaoping Qin; Daniel Perry; John J Voorhees; Taihao Quan
Journal:  Aging Cell       Date:  2015-10-08       Impact factor: 9.304

10.  Amyloid fibril in hereditary cerebral hemorrhage with amyloidosis (HCHWA) is related to the gastroentero-pancreatic neuroendocrine protein, gamma trace.

Authors:  D H Cohen; H Feiner; O Jensson; B Frangione
Journal:  J Exp Med       Date:  1983-08-01       Impact factor: 14.307

View more
  2 in total

1.  NAC blocks Cystatin C amyloid complex aggregation in a cell system and in skin of HCCAA patients.

Authors:  Michael E March; Alvaro Gutierrez-Uzquiza; Asbjorg Osk Snorradottir; Leticia S Matsuoka; Noelia Fonseca Balvis; Thorgeir Gestsson; Kenny Nguyen; Patrick M A Sleiman; Charlly Kao; Helgi J Isaksson; Birkir Thor Bragason; Elias Olafsson; Astridur Palsdottir; Hakon Hakonarson
Journal:  Nat Commun       Date:  2021-03-23       Impact factor: 14.919

2.  Clearance of interstitial fluid (ISF) and CSF (CLIC) group-part of Vascular Professional Interest Area (PIA): Cerebrovascular disease and the failure of elimination of Amyloid-β from the brain and retina with age and Alzheimer's disease-Opportunities for Therapy.

Authors:  Roxana O Carare; Roxana Aldea; Nivedita Agarwal; Brian J Bacskai; Ingo Bechman; Delphine Boche; Guojun Bu; Diederik Bulters; Alt Clemens; Scott E Counts; Mony de Leon; Per K Eide; Silvia Fossati; Steven M Greenberg; Edith Hamel; Cheryl A Hawkes; Maya Koronyo-Hamaoui; Atticus H Hainsworth; David Holtzman; Masafumi Ihara; Angela Jefferson; Raj N Kalaria; Christopher M Kipps; Katja M Kanninen; Ville Leinonen; JoAnne McLaurin; Scott Miners; Tarja Malm; James A R Nicoll; Fabrizio Piazza; Gesine Paul; Steven M Rich; Satoshi Saito; Andy Shih; Henrieta Scholtzova; Heather Snyder; Peter Snyder; Finnbogi Rutur Thormodsson; Susanne J van Veluw; Roy O Weller; David J Werring; Donna Wilcock; Mark R Wilson; Berislav V Zlokovic; Ajay Verma
Journal:  Alzheimers Dement (Amst)       Date:  2020-08-03
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.